crb® SARS-CoV-2 IgG/IgM Assay

3,000$

crb® SARS-CoV-2 Assay is a Point of Care Immunochromatographic in vitro assay for the differential detection of IgG & IgM antibodies to SARS-CoV-2 virus in human serum, plasma and/or whole blood samples

Benefits of crb® SARS-CoV-2 IgG/IgM Assay

Fast: Test results in 10-20 minutes.

Flexible: Qualitative detection of SARS-CoV-2 virus.

Convenient: Point of Care.

Highly Informative: Enables early screening and rapid diagnosis of SARS-CoV-2 virus infection.

 

Format: 25 cassettes/Kit (Pack of 40 Kits)

Description

crb® SARS-CoV-2 Assay is a Point of Care Immunochromatographic in vitro assay for the differential detection of IgG & IgM antibodies to SARS-CoV-2 virus in human serum, plasma and/or whole blood samples. This assay only provides a preliminary result. Clinical expertise and professional judgment should be sought to further evaluate the result of the test.

SKU MD014
Detection
  • SARS-CoV-2 virus
Specimen
  • Whole blood
  • Serum
  • Plasma
Kit Content
  • Test device
  • Buffer
Test per kit 25

 

 

Registration Status

CE-IVD Registered
FDA-IVD Clinical Testing

IFU & SDS

Shelf life: 24 months at room temperature.